Sutter Health

San Francisco, California 94118

6 studies enrolling now · 13 studies all time

What they study most

ALS, Acute Ischemic Stroke, Alzheimer Disease, Aortic Insufficiency, Aortic Regurgitation, Aortic Valve Disease, Aortic Valve Insufficiency, Aortic Valve Replacement, Aortic Valve Stenosis, Atrial Fibrillation, Atrioventricular Reentrant Tachycardia, Cancer

Studies at this site

• A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma — Recruiting now
• Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH) — Recruiting now
• [18F]PI-2620 Phase 3 Histopathological Study — Recruiting now
• Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE) — Recruiting now
• The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves). — Recruiting now
• Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic Adenocarcinoma — Available (expanded access)
• The JenaValve ALIGN-AR LVAD Registry — Running, not enrolling
• Safety Study of Oral Edaravone Administered in Subjects With ALS — Completed
• SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial — Running, not enrolling
• The STRIVE Study: Development of a Blood Test for Early Detection of Multiple Cancer Types — Completed
• EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial) — Running, not enrolling
• A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma (NHL) and in Combination With Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer — Stopped early
• Vektor vMap™ Clinical Validation Study — Completed